Overview

Pegteograstim in Children With Solid Tumors

Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of pegteograstim on chemotherapy-induced neutropenia in children with solid tumors
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Collaborator:
Green Cross Corporation